A Study of the Safety, Tolerability and Pharmacokinetics of Idazoxan in Healthy Participants

Sex: All

Ages: 18 Years – 55 Years

Healthy volunteers: 1

Phase: PHASE1

Enrollment: 110

Sponsor: Terran Biosciences Australia Pty Ltd

Summary

Four-part study of the safety, tolerability and pharmacokinetics of 3 forms of TR-01-XRR, 1 form of TR-01-XRS, and 1 form of TR-01-XR in healthy adults.

Eligibility Criteria

Inclusion Criteria:BMI between 18 and 32 kg/m2Medically healthy without clinically significant or relevant medical historyExclusion Criteria:Evidence of recurrent disease, physical illness or medical condition that could affect action, absorption or disposition of investigational productsUse of any prescription or over-the-counter medication that cannot be discontinued for the duration of the studyImpaired renal functionCardiac abnormalitiesPositive HIV, HBsAg or HCVPositive test for alcohol, drugs of abuse or cotinine

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05727189). StuddyBuddy aggregates publicly available trial information.